Substance use of disorders in HIV-infected patients: impact and new treatment strategies.
Substance use of disorders--including alcohol, cocaine, and opiod dependencies--are common in HIV-infected patients. Untreated substance use disorders result in poor HIV disease treatment outcomes; however, several new treatment strategies have emerged in recent years. Combined medication and counseling therapies are effective for alcohol and opioid dependencies, and counseling treatments are effective for cocaine dependence. Office-based treatment with buprenorphine offers the opportunity for coordinated treatment of HIV disease and opioid dependence. This article summarizes a presentation by David A. Fiellin, MD, in March 2004 at the International AIDS Society-USA New York course.
Yale University School of Medicine, New Haven, CT, USA.
David A
DA
Fiellin
D019973:Alcohol-Related Disorders; D019380:Anti-HIV Agents / Q000627:therapeutic use; D019970:Cocaine-Related Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008297:Male; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D010349:Patient Compliance; D018570:Risk Assessment; D012720:Severity of Illness Index; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D009292:Narcotic Antagonists